Indication

Cervical Adenosarcoma

1 clinical trial

2 drugs

Clinical trial

Targeted Complex Therapy for Advanced Melanoma, Gynecologic Cancers, and Other Malignancies: Nab-Paclitaxel (Abraxane)/Bevacizumab Complex (AB-Complex)

Status: Active (not recruiting), Estimated PCD: 2024-06-30

Drug

Drug